Motus gi amends royalty agreement

– amended agreement eliminates approximately $1.0m in contingent royalty obligations from balance sheet –  – canceled royalty rights in exchange for common stock expected to improve company's stockholder equity, and simplify ongoing exploration of strategic and financing alternatives to maximize stockholder value – fort lauderdale, fla., sept. 14, 2023 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) (“motus gi” or the “company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today it has reached an agreement to amend the royalty payment rights and, subsequently, cancelled the royalty rights in exchange for an aggregate of 1,455,641 shares of motus common stock, effective as of september 12, 2023.
MOTS Ratings Summary
MOTS Quant Ranking